Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24842047 | 0.85 | ADRB3 (0.40) | ADRB3TMEM97HRH3MAPTNOTUM | |
| SCHEMBL30162758 | 0.84 | ADRB3 (0.33) | ADRB3TMEM97HRH3MAPTNOTUM | |
| SCHEMBL30162689 | 0.83 | ADRB3 (0.32) | ADRB3TMEM97HRH3NOTUM | |
| SCHEMBL30163009 | 0.77 | SSTR4 (0.33) | — | |
| SCHEMBL30162850 | 0.76 | ADRB3 (0.33) | ADRB3TMEM97HRH3NOTUM | |
| SCHEMBL6853830 | 0.76 | NOTUM (0.39) | ADRB3TMEM97HRH3MAPTNOTUM | |
| SCHEMBL6854963 | 0.74 | NOTUM (0.40) | ADRB3TMEM97HRH3NOTUM | |
| SCHEMBL15199612 | 0.74 | ADRB3 (0.44) | ADRB3TMEM97HRH3MAPTNOTUM | |
| SCHEMBL6855523 | 0.74 | TSHR (0.39) | ADRB3TMEM97HRH3NOTUM | |
| SCHEMBL31728124 | 0.73 | NOTUM (0.43) | ADRB3TMEM97HRH3MAPTNOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023277517-A1 | ACYCLIC NUCLEIC ACID MIMIC COMPRISING PENTACYCLIC BASE | 동아대학교 산학협력단 | 2023-01-05 | — | — | WO | claimed |
| WO-2023277517-A1 | ACYCLIC NUCLEIC ACID MIMIC COMPRISING PENTACYCLIC BASE | 동아대학교 산학협력단 | 2023-01-05 | — | — | WO | disclosed |